Medical Properties Trust (NYSE:MPW) Price Target Lowered to $14.00 at Barclays

Medical Properties Trust (NYSE:MPW – Get Rating) had its target price trimmed by Barclays from $17.00 to $14.00 in a report published on Monday morning, The Fly reports.

A number of other equities analysts have also recently issued reports on MPW. KeyCorp dropped their target price on Medical Properties Trust from $18.00 to $16.00 and set an overweight rating for the company in a report on Thursday, January 19th. Bank of America raised Medical Properties Trust from a neutral rating to a buy rating and increased their target price for the stock from $13.00 to $16.00 in a report on Monday, November 14th. They noted that the move was a valuation call. Credit Suisse Group dropped their target price on Medical Properties Trust from $13.00 to $11.00 and set a neutral rating for the company in a report on Friday. Finally, Mizuho dropped their target price on Medical Properties Trust from $20.00 to $18.00 in a report on Friday, December 2nd. Six equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Medical Properties Trust currently has an average rating of Moderate Buy and a consensus price target of $16.09.

Medical Properties Trust Trading Down 1.9 %

Medical Properties Trust stock opened at $10.35 on Monday. The business has a 50 day moving average price of $12.27 and a two-hundred day moving average price of $12.57. The company has a quick ratio of 1.98, a current ratio of 1.92 and a debt-to-equity ratio of 1.19. The stock has a market cap of $6.19 billion, a price-to-earnings ratio of 6.90, a price-to-earnings-growth ratio of 0.65 and a beta of 0.93. Medical Properties Trust has a 12 month low of $9.90 and a 12 month high of $21.63.

Medical Properties Trust Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 13th. Investors of record on Thursday, March 16th will be given a dividend of $0.29 per share. The ex-dividend date of this dividend is Wednesday, March 15th. This represents a $1.16 dividend on an annualized basis and a yield of 11.21%. Medical Properties Trust’s dividend payout ratio (DPR) is presently 77.33%.

Institutional Investors Weigh In On Medical Properties Trust

A number of large investors have recently bought and sold shares of MPW. Marshall Wace LLP grew its position in Medical Properties Trust by 348.8% during the 3rd quarter. Marshall Wace LLP now owns 7,104,051 shares of the real estate investment trust’s stock worth $84,256,000 after acquiring an additional 5,521,226 shares during the last quarter. State Street Corp lifted its stake in shares of Medical Properties Trust by 11.7% during the first quarter. State Street Corp now owns 36,158,910 shares of the real estate investment trust’s stock valued at $774,593,000 after acquiring an additional 3,800,294 shares during the period. Bank of New York Mellon Corp boosted its holdings in Medical Properties Trust by 24.5% in the third quarter. Bank of New York Mellon Corp now owns 17,071,940 shares of the real estate investment trust’s stock valued at $202,473,000 after acquiring an additional 3,355,195 shares during the last quarter. Norges Bank acquired a new stake in Medical Properties Trust in the fourth quarter worth about $34,612,000. Finally, Man Group plc bought a new stake in Medical Properties Trust during the 4th quarter worth about $32,630,000. 80.31% of the stock is currently owned by institutional investors.

About Medical Properties Trust

(Get Rating)

Medical Properties Trust, Inc is a self-advised real estate investment trust, engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities.